Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 668 participants.

Also called NCT02378350

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 668 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02378350
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02378350. Randomized; no masking; primary purpose treatment. Start 2014-03-26 (actual); primary completion 2017-09-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China
Condition
End Stage Renal Disease
Intervention (Device)
Hemodialysis treatment (no specific device is defined)
Intervention (Drug)
Peritoneal Dialysis treatment (no specific drug is defined)
Lead sponsor
Vantive Health LLC (class: industry)
Collaborator
Baxter Healthcare Corporation (class: industry)

Record details

Record id
cardio:ct-nct02378350
Content hash
4199f4b9d8498abc42293a82bb3520c31e8ff9c2d831f354f1f3046ce94ee940